Filing Flows

Filing Flows › 8-K events › Tenon Medical

Tenon Medical: entry into a material definitive agreement

Form 8-K filed Oct 22, 2026 · items 1.01

What the filing says

As previously disclosed, on August 27, 2026, Tenon Medical, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with a certain institutional investor (the “Investor”). On October 16, 2026, the Company and the Investor entered into a waiver (the “Investor

Read the filing on SEC EDGAR →

What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Every item ranked →

What this kind of filing means

Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.

Tenon Medical at a glance

Latest quarterQ2 2026
Revenue$1.3M
Revenue Y/Y+127%
Operating margin-262.2%
IndustrySurgical & Medical Instruments & Apparatus

Tenon Medical, Q2 2026: revenue $1.3M (+127% year over year), operating margin -262.2%. The chart follows the revenue to costs, profit and cash.

Tenon Medical: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent share offerings

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.